Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs - Global

Rating :
55/99

BSE: 506197 | NSE: BLISSGVS

171.70
04-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  176.85
  •  176.85
  •  171.50
  •  176.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  461372
  •  798.58
  •  181.60
  •  81.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,771.03
  • 25.60
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,788.67
  • 0.29%
  • 2.31

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.60%
  • 10.99%
  • 12.77%
  • FII
  • DII
  • Others
  • 23.37%
  • 5.73%
  • 5.54%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.16
  • 4.74
  • -5.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.69
  • -4.57
  • -8.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.12
  • 3.35
  • 18.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.85
  • 18.90
  • 18.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.77
  • 2.92
  • 2.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.21
  • 8.67
  • 8.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
151.54
210.12
-27.88%
129.55
211.53
-38.76%
119.80
244.37
-50.98%
147.85
220.44
-32.93%
Expenses
119.54
184.66
-35.26%
110.07
162.57
-32.29%
103.95
212.43
-51.07%
114.90
176.90
-35.05%
EBITDA
32.00
25.47
25.64%
19.48
48.96
-60.21%
15.85
31.94
-50.38%
32.95
43.54
-24.32%
EBIDTM
21.12%
12.12%
15.03%
23.15%
14.01%
13.07%
22.28%
19.75%
Other Income
2.74
12.90
-78.76%
7.04
2.11
233.65%
16.60
2.79
494.98%
5.52
-3.90
-
Interest
0.38
1.05
-63.81%
1.83
0.89
105.62%
2.39
0.93
156.99%
1.08
0.96
12.50%
Depreciation
4.31
3.50
23.14%
4.29
2.78
54.32%
3.34
2.20
51.82%
2.97
2.19
35.62%
PBT
30.05
33.81
-11.12%
20.40
47.40
-56.96%
13.33
31.60
-57.82%
34.41
36.48
-5.67%
Tax
8.44
2.95
186.10%
3.75
14.04
-73.29%
7.76
12.81
-39.42%
8.96
9.25
-3.14%
PAT
21.61
30.86
-29.97%
16.65
33.37
-50.10%
5.57
18.79
-70.36%
25.45
27.23
-6.54%
PATM
14.26%
14.69%
12.85%
15.77%
7.11%
7.69%
17.21%
12.35%
EPS
2.10
2.99
-29.77%
1.61
3.24
-50.31%
0.54
1.82
-70.33%
2.47
2.64
-6.44%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
548.74
689.31
898.57
814.64
798.44
546.89
407.13
344.64
396.63
267.07
218.84
Net Sales Growth
-38.10%
-23.29%
10.30%
2.03%
46.00%
34.33%
18.13%
-13.11%
48.51%
22.04%
 
Cost Of Goods Sold
4,886.26
439.97
612.26
391.13
358.93
237.18
152.77
132.01
167.90
145.83
112.20
Gross Profit
-4,337.52
249.34
286.31
423.52
439.51
309.72
254.37
212.63
228.72
121.24
106.65
GP Margin
-790.45%
36.17%
31.86%
51.99%
55.05%
56.63%
62.48%
61.70%
57.67%
45.40%
48.73%
Total Expenditure
448.46
566.08
740.93
617.50
595.70
391.17
303.70
273.42
285.47
195.73
160.11
Power & Fuel Cost
-
5.88
4.76
5.49
5.58
4.72
4.36
2.93
2.18
1.02
0.54
% Of Sales
-
0.85%
0.53%
0.67%
0.70%
0.86%
1.07%
0.85%
0.55%
0.38%
0.25%
Employee Cost
-
53.69
42.32
69.23
61.35
33.74
29.43
23.46
15.08
6.26
3.53
% Of Sales
-
7.79%
4.71%
8.50%
7.68%
6.17%
7.23%
6.81%
3.80%
2.34%
1.61%
Manufacturing Exp.
-
6.30
4.95
4.88
5.39
25.65
29.98
41.44
37.17
12.66
15.88
% Of Sales
-
0.91%
0.55%
0.60%
0.68%
4.69%
7.36%
12.02%
9.37%
4.74%
7.26%
General & Admin Exp.
-
12.99
17.05
39.48
36.36
24.68
17.07
15.16
14.63
7.36
5.21
% Of Sales
-
1.88%
1.90%
4.85%
4.55%
4.51%
4.19%
4.40%
3.69%
2.76%
2.38%
Selling & Distn. Exp.
-
28.83
34.72
62.09
92.46
42.51
47.05
35.12
40.26
21.13
15.75
% Of Sales
-
4.18%
3.86%
7.62%
11.58%
7.77%
11.56%
10.19%
10.15%
7.91%
7.20%
Miscellaneous Exp.
-
18.43
24.86
45.21
35.63
22.71
23.03
23.30
8.25
1.47
15.75
% Of Sales
-
2.67%
2.77%
5.55%
4.46%
4.15%
5.66%
6.76%
2.08%
0.55%
3.20%
EBITDA
100.28
123.23
157.64
197.14
202.74
155.72
103.43
71.22
111.16
71.34
58.73
EBITDA Margin
18.27%
17.88%
17.54%
24.20%
25.39%
28.47%
25.40%
20.67%
28.03%
26.71%
26.84%
Other Income
31.90
37.12
37.63
26.54
12.51
24.35
20.29
28.00
14.07
15.75
1.87
Interest
5.68
5.41
4.41
22.80
19.69
18.61
16.41
17.98
9.72
4.03
2.15
Depreciation
14.91
12.59
8.94
21.38
20.14
13.26
11.30
10.68
6.03
3.65
5.47
PBT
98.19
142.35
181.92
179.49
175.40
148.19
96.02
70.56
109.48
79.42
52.98
Tax
28.91
33.71
55.25
56.63
62.72
48.05
34.63
29.53
49.90
26.88
12.35
Tax Rate
29.44%
26.14%
30.37%
38.98%
35.76%
32.42%
36.07%
41.85%
45.58%
33.85%
23.31%
PAT
69.28
97.26
123.72
58.78
82.04
82.49
59.91
40.99
57.72
52.54
40.63
PAT before Minority Interest
66.01
95.25
126.66
88.66
112.68
100.15
61.39
41.03
59.58
52.54
40.63
Minority Interest
-3.27
2.01
-2.94
-29.88
-30.64
-17.66
-1.48
-0.04
-1.86
0.00
0.00
PAT Margin
12.63%
14.11%
13.77%
7.22%
10.28%
15.08%
14.72%
11.89%
14.55%
19.67%
18.57%
PAT Growth
-37.16%
-21.39%
110.48%
-28.35%
-0.55%
37.69%
46.16%
-28.98%
9.86%
29.31%
 
EPS
6.72
9.43
12.00
5.70
7.96
8.00
5.81
3.98
5.60
5.10
3.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
735.61
646.00
536.24
486.62
412.62
337.08
286.88
258.01
210.66
166.62
Share Capital
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
725.30
635.68
525.92
476.31
402.31
326.77
276.57
247.69
200.35
156.31
Non-Current Liabilities
46.47
37.99
12.92
32.81
49.55
67.52
95.65
96.92
39.34
3.86
Secured Loans
37.24
32.54
5.92
25.58
29.62
55.03
78.80
89.97
37.63
3.65
Unsecured Loans
0.00
0.00
0.00
0.00
8.62
2.23
8.79
1.33
0.00
0.00
Long Term Provisions
2.44
1.75
1.91
2.05
1.81
1.40
1.10
0.74
0.51
0.58
Current Liabilities
232.18
207.03
299.40
437.09
378.97
242.68
307.66
202.19
59.74
42.64
Trade Payables
94.15
78.88
58.43
98.25
108.49
80.33
82.35
118.15
40.15
31.40
Other Current Liabilities
54.63
50.24
124.46
99.93
52.76
70.30
42.12
24.45
6.10
4.35
Short Term Borrowings
66.39
64.30
105.66
187.47
62.12
61.04
57.05
45.16
5.90
3.29
Short Term Provisions
17.01
13.61
10.85
51.45
155.60
31.00
126.14
14.44
7.58
3.61
Total Liabilities
1,029.02
904.88
860.04
1,022.90
874.24
662.17
700.35
570.92
309.74
213.12
Net Block
240.97
144.97
136.48
303.86
225.25
234.38
213.31
168.23
40.03
19.93
Gross Block
276.07
169.89
157.47
326.83
300.74
293.82
262.45
205.92
64.41
40.84
Accumulated Depreciation
35.10
24.92
20.99
22.97
75.48
59.44
49.14
37.69
24.38
20.91
Non Current Assets
256.07
211.39
170.25
456.97
291.23
244.66
229.67
219.61
100.21
56.57
Capital Work in Progress
0.00
46.74
0.47
4.03
9.10
0.00
4.33
0.65
6.91
7.55
Non Current Investment
0.72
0.72
6.30
1.05
0.11
0.01
0.01
0.01
0.00
0.00
Long Term Loans & Adv.
13.15
18.63
26.72
11.45
56.77
10.27
12.02
50.72
53.28
29.09
Other Non Current Assets
1.24
0.33
0.29
136.58
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
772.95
693.49
689.79
565.93
583.00
417.08
469.26
348.89
209.54
156.55
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.80
0.00
Inventories
74.14
77.37
59.03
49.30
38.67
33.70
32.53
32.52
12.68
11.61
Sundry Debtors
547.91
460.73
298.48
254.45
300.93
247.47
215.03
244.64
128.59
119.61
Cash & Bank
103.32
106.63
88.86
150.50
78.18
57.29
80.37
50.35
58.01
17.98
Other Current Assets
47.58
26.21
97.11
33.24
165.22
78.62
141.34
21.37
9.46
7.35
Short Term Loans & Adv.
30.71
22.55
146.30
78.44
149.92
60.69
130.30
8.92
5.09
2.62
Net Current Assets
540.76
486.47
390.39
128.84
204.03
174.40
161.60
146.70
149.80
113.91
Total Assets
1,029.02
904.88
860.04
1,022.90
874.23
662.17
700.35
570.91
309.75
213.12

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
45.28
39.95
17.64
289.47
112.95
48.94
41.15
6.50
35.46
0.00
PBT
128.97
181.91
179.49
175.40
148.19
96.02
70.56
109.48
79.42
0.00
Adjustment
24.37
-10.97
17.55
36.24
18.18
22.48
24.11
9.71
4.76
0.00
Changes in Working Capital
-69.22
-183.07
-140.80
113.48
-8.33
-60.94
-19.30
-73.94
-37.83
0.00
Cash after chg. in Working capital
84.12
-12.13
56.24
325.13
158.05
57.56
75.36
45.25
46.35
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-38.84
52.08
-38.61
-35.66
-45.10
-8.63
-34.21
-38.75
-10.89
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-48.95
-73.52
50.24
-231.25
-49.84
-38.98
-10.90
-124.05
-21.91
0.00
Net Fixed Assets
-65.98
-52.48
-1.04
42.08
-5.32
-28.78
-12.86
-12.91
-16.65
Net Investments
0.01
0.16
2.37
-0.95
-1.36
0.00
-0.01
-18.19
-1.03
Others
17.02
-21.20
48.91
-272.38
-43.16
-10.20
1.97
-92.95
-4.23
Cash from Financing Activity
-3.83
16.83
-75.98
-10.13
-40.25
-43.26
-8.47
109.89
26.48
0.00
Net Cash Inflow / Outflow
-7.50
-16.74
-8.10
48.09
22.85
-33.31
21.77
-7.66
40.02
0.00
Opening Cash & Equivalents
15.04
36.95
47.41
0.00
5.09
49.57
27.79
58.01
17.98
0.00
Closing Cash & Equivalent
15.34
15.04
36.95
47.41
27.60
16.26
49.57
50.35
58.01
0.00

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
71.32
62.63
51.99
47.18
40.00
32.64
27.67
24.78
20.42
16.15
ROA
9.85%
14.35%
9.42%
11.88%
13.04%
9.01%
6.46%
13.53%
20.09%
19.06%
ROE
13.79%
21.43%
17.34%
25.06%
26.73%
19.74%
15.17%
25.56%
27.85%
24.38%
ROCE
16.75%
26.58%
24.61%
31.06%
32.07%
23.57%
20.56%
36.18%
38.76%
31.53%
Fixed Asset Turnover
3.09
5.49
3.37
2.56
1.85
1.47
1.48
2.95
5.09
5.37
Receivable days
267.05
154.20
123.80
126.33
182.13
206.07
241.81
171.03
169.17
199.09
Inventory Days
40.11
27.70
24.25
20.01
24.04
29.51
34.22
20.71
16.56
19.33
Payable days
58.13
35.01
51.74
67.63
95.25
108.77
148.76
105.12
67.61
73.84
Cash Conversion Cycle
249.03
146.89
96.31
78.70
110.92
126.81
127.26
86.63
118.11
144.57
Total Debt/Equity
0.16
0.16
0.22
0.46
0.32
0.47
0.60
0.58
0.21
0.05
Interest Cover
24.84
42.21
7.37
9.91
8.96
6.85
4.92
12.27
20.70
25.67

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.